Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis

<div>(a) Forest plot showing subgroup analysis of OS. (b) Forest plot showing subgroup analysis of PFS. PD-L1: programmed cell death ligand 1. CPS: combined positive score; TPS: tumor positive score; FP: fluorouracil + platinum; TP: paclitaxel + platinum; OS: overall survival; PFS: progression-free survival; HR: hazard ratio.</div>

Journal of Clinical Pharmacy and Therapeutics

fig5

Figure 5

Figure 5: Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis 

Figure 5 | Comparison of Efficacy and Safety of First-Line Chemoimmunotherapy in Advanced Esophageal Squamous Cell Carcinoma: A Systematic Review and Network Meta-Analysis 